Product Images Isradipine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Isradipine NDC 64850-911 by Elite Laboratories, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

isradipine-2.5mg-100count - ELIT 0210 1up

isradipine-2.5mg-100count - ELIT 0210 1up

This is a description for Isradipine capsules, USP with a strength of 2.5 mg. The capsules are manufactured by Elite Laboratories Inc. and come in a container of 100 capsules. The usual dosage instructions are provided in the accompanying literature, and it's only meant for Rx use. Patients are advised to keep the medication in a tightly closed, light-resistant container and keep it out of the reach of children. The NDC number for this medication is 64850-910-01.*

isradipine-5mg-100count - ELIT 0211 1up

isradipine-5mg-100count - ELIT 0211 1up

Isradipine capsules, USP with a strength of 5 mg, containing Isradipine as the active ingredient, are available in a container of 100 capsules. The medication is manufactured by Elite Laboratories Inc. and the usual dosage information is provided in the accompanying literature. The medication should be stored at room temperature, between 20°-25°C (68°-77°F), in a tightly closed container, away from children's reach. The container must be tight, light-resistant, and have a child-resistant closure as per the USP. The National Drug Code (NDC) of the medication is 64850-911-01.*

Structural formula of Isradipine - image 01

Structural formula of Isradipine - image 01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.